Therapy Areas: Allergy
17 May 2019 - - US-based CEL-SCI Corp.'s (NYSE American: CVM) senior vice president of research, cellular immunology Daniel Zimmerman, Ph.D. has presented new LEAPS data at the American Asso...
16 May 2019 - - US-based clinical-stage company Vedanta Biosciences has raised an additional USD 18.5m as an extension of its Series C financing, bringing the total for the round to USD 45.5m, the com...
10 May 2019 - - US-based drug delivery platform developer Mati Therapeutics Inc. has completed a Phase II clinical trial evaluating the safety and efficacy of nepafenac delivered in Mati's propri...
9 May 2019 - - The Opposition Division of the European Patent Office has upheld US-based clinical-stage company Vedanta Biosciences' foundational patent EP2575835, strengthening Vedanta's in...
9 May 2019 - Therapeutic antibodies company AbCellera reported on Wednesday the launch of a partnership with the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (N...
7 May 2019 - - US-based biotechnology company Axial Biotherapeutics has presented new preclinical data on AB-2004, its orally administered, drug candidate that has demonstrated the ability to repair l...